CSF1R and cancer: Consistent with the role of CSF-1-dependent, TAM-activated tumor invasion, high CSF-1 levels are also associated with poor prognoses in many cancers, leading to the testing of a variety of anti-CSF-1/CSF-1R therapies to either reduce or reprogram TAMs to treat cancer [70].